• Wed. Jan 19th, 2022

European green pass from 1 July: first dose, test, quarantine

Byeditorial

Jun 1, 2021

Travel, tourism, quarantine, tampons. What is there to know about the European green pass? The digital EU Covid certificate, or Green Pass, will help travelers within the EU who hold it to avoid being tested and / or quarantined when traveling within the EU. From 1 July, when the regulation will come into force, the Pass will be a right for all EU citizens who meet the requirements: it applies to those who have been vaccinated, for those who have recovered from Covid-19 and for those who undergo a test and is negative. The Gateway, the EU IT platform that makes the Pass possible, will work from today and states that intend to anticipate the times can use it immediately. If obtaining the Pass will be a right, its use varies from State to State: the competences are national and the Council can only recommend, not impose. And even when the proposal made yesterday by the Commission is approved by the Council, it will remain a non-binding recommendation: in the last year the Council’s recommendations have often been disregarded by member countries. With all these warnings, here are the details: VACCINATED – The Pass will be valid from fourteen days after the last dose of the anti-Covid vaccine. Beginning that day, fully vaccinated people, i.e. with two doses for AstraZeneca, Pfizer / BioNTech and Moderna and with one dose for Janssen (J&J), who hold the certificate, should be exempt from testing and quarantines while traveling. The same must apply to people who have recovered and who have received only one dose of the vaccine, which is considered sufficient to be protected from the disease. A country is free to choose to recognize and issue the Pass even after the first dose, but each State can decide to behave as it sees fit, in this case: therefore, for example, Italy can issue the Pass after the first dose, but Denmark is free not to recognize it and to ask for a test. If a member state accepts a vaccination test to remove the restrictions inside after the first dose, then it must also accept EU vaccine passes, under the same conditions. and / or quarantines in the 180 days following the positive PCR test, which certifies the infection (validity is from the eleventh day after the test, once the period of contagiousness has ended). cured, then the test remains, which the pass certifies and which is thus also recognized abroad. A standard validity period is proposed for the tests (today each country determines the validity independently): for PCR or molecular tests the validity is 72 hours, while for rapid antigenic ones it is 48 hours. The fast ones, considered increasingly reliable, are recommended, but states are free to choose whether or not to accept them for the purposes of the Pass. Tests are paid, vaccines are not: this element of objective discrimination has not been removed in the negotiations between Parliament and the Council, due to the Council’s firm opposition to imposing free tests, as requested by the Chamber. avoid separating households at the border, minors traveling with parents exempt from quarantine, for example because they are vaccinated, should also be exempted from quarantine. Children under 6 years of age should also be exempted from testing, but those aged 6 and over will have to undergo tests EMERGENCY BRAKE – An emergency brake mechanism is in place: States can reintroduce restrictions also for vaccinated and cured people, if the epidemiological situation deteriorates rapidly or where a high prevalence of worrying variants is reported. NEW THRESHOLDS FOR THE ZONES – In general, beyond the pass holders, they are also relatively simplified the necessary requirements to travel. For travelers arriving from green areas (according to the map updated every Thursday by the ECDC), there should be no restrictions. For those arriving from the orange areas, it is possible to request a test (rapid or Pcr) before departure. For those traveling from a red zone, states can request a quarantine in the absence of a negative PCR or rapid test. For travelers from dark red areas, the principle holds that movement from these areas should be “strongly discouraged”. In these cases, testing and (not ‘or’) quarantine requirements should remain. For the orange areas (today a large part of Italy is orange, with the exception of Valle d’Aosta, Tuscany, Campania, Puglia, Basilicata and Calabria, which are red) it is proposed to increase the threshold of the cumulative notification rate of new cases in the last 14 days from 50 to 75; for the red areas the rate is raised from the current 50-150 to 75-150.

One thought on “European green pass from 1 July: first dose, test, quarantine”
  1. editorial says:

    https://connect.informs.org/network/members/profile?UserKey=3c52bf5c-f283-4c65-9ac4-82b9e0bd507d
    https://connect.informs.org/network/members/profile?UserKey=577a2b14-7cfa-4799-9fd5-e775f48646c4
    https://connect.informs.org/network/members/profile?UserKey=80f1fd2f-f1f4-42f8-86de-2ce89d0a2415
    https://connect.informs.org/network/members/profile?UserKey=a20ef610-e293-4788-b9f5-7b5263363b8b
    https://connect.informs.org/network/members/profile?UserKey=72346270-4411-4786-ab9f-a03dc749bc30
    https://connect.informs.org/network/members/profile?UserKey=59ad2b0f-bbe2-4bb5-91e2-b26d81eda42e
    https://connect.informs.org/network/members/profile?UserKey=aaaf5f59-051e-4e75-95d2-1500ce7e8b57
    https://connect.informs.org/network/members/profile?UserKey=c051e698-1c77-431e-8c01-0002a09b7f18
    https://connect.informs.org/network/members/profile?UserKey=43f32c8a-98d2-4653-98b9-699ed51b723b
    https://connect.informs.org/network/members/profile?UserKey=6d6ca77e-f3b2-46f8-81a0-4b7ae42a8c7f
    https://connect.informs.org/network/members/profile?UserKey=6caef829-6f20-4094-8268-39408b7d6dab
    https://connect.informs.org/network/members/profile?UserKey=9eb9dd10-1130-4445-8048-0838e8eb4427
    https://connect.informs.org/network/members/profile?UserKey=9beb3e61-1f6c-4467-b91b-08c5e3550bf8
    https://connect.informs.org/network/members/profile?UserKey=e0b1a3eb-55fb-4047-a4a7-da3e26065365
    https://connect.informs.org/network/members/profile?UserKey=80e7044f-301f-41ff-bb21-7438fee08596
    https://connect.informs.org/network/members/profile?UserKey=c49fb4fe-cd70-4af2-a840-4427b0ea9adc
    https://connect.informs.org/network/members/profile?UserKey=47be9218-510b-40a7-9e79-b3fa38d957d7
    https://connect.informs.org/network/members/profile?UserKey=4acb9572-17bc-4ad7-86e6-798c4341fab6
    https://connect.informs.org/network/members/profile?UserKey=292784ba-10a4-4064-b484-c529241a97cb
    https://connect.informs.org/network/members/profile?UserKey=88cca8ef-0ead-4806-bbe1-2fa1aa20f30a
    https://connect.informs.org/network/members/profile?UserKey=c2d8867a-f7f6-4911-a3c2-ebdc0ccbf36b
    https://connect.informs.org/network/members/profile?UserKey=44db8765-58f6-4f07-b5c7-287daa6bd0e5
    https://connect.informs.org/network/members/profile?UserKey=c3838164-d16e-48ea-983c-b686145c6f01
    https://connect.informs.org/network/members/profile?UserKey=1bda6ef8-254a-4d34-b49b-341ece35e2f5
    https://connect.informs.org/network/members/profile?UserKey=47c1827a-91d0-4911-add5-6b95a74b64fd
    https://connect.informs.org/network/members/profile?UserKey=0bfbc4d7-1109-4ab4-a788-ada867925201
    https://connect.informs.org/network/members/profile?UserKey=8e8e59eb-ef85-4424-8f6f-97d055519193
    https://connect.informs.org/network/members/profile?UserKey=4c6216d6-5820-4bdf-8867-0ce9e80e0435
    https://connect.informs.org/network/members/profile?UserKey=9983dbf7-da24-49de-8560-c1d97c0d1bc1
    https://connect.informs.org/network/members/profile?UserKey=27ef0014-dd4e-4ea8-9885-9097284d1a84
    https://connect.informs.org/network/members/profile?UserKey=06efd44c-f8a7-49a2-8aa0-e54be34e0200
    https://connect.informs.org/network/members/profile?UserKey=00397a29-4420-46a5-ae32-1f6cf4038df1
    https://connect.informs.org/network/members/profile?UserKey=339a1cc3-26b3-4b1b-afe4-b873bd87fbab
    https://connect.informs.org/network/members/profile?UserKey=72dda77d-dd9b-4304-b809-72305d36c700
    https://connect.informs.org/network/members/profile?UserKey=95518636-dfa3-4828-9bce-d59a781686fe
    https://connect.informs.org/network/members/profile?UserKey=93b0473d-4090-4f25-adfe-bd978e355d4a
    https://connect.informs.org/network/members/profile?UserKey=1f3e4694-9bff-444a-8820-de78711d0e36
    https://connect.informs.org/network/members/profile?UserKey=6c6548a2-f586-4ea0-8998-b0abf51dddb1
    https://connect.informs.org/network/members/profile?UserKey=8c9dea5f-f156-4fa0-a1e2-591877a8223b
    https://connect.informs.org/network/members/profile?UserKey=7eaf29cf-6b94-43c2-b662-263bca827315
    https://connect.informs.org/network/members/profile?UserKey=82d9d740-c234-419b-9bf2-65ff761e4389
    https://connect.informs.org/network/members/profile?UserKey=b9560d81-5fd8-4b0b-b82f-9e7653e6ba21
    https://connect.informs.org/network/members/profile?UserKey=ce77d37d-3de9-4ee1-9579-d7e2f29f4051
    https://connect.informs.org/network/members/profile?UserKey=df5e50c1-ae8f-456e-a036-b2324754cffd
    https://connect.informs.org/network/members/profile?UserKey=5808e2fb-0ac6-4b24-baed-28274631ef2c
    https://connect.informs.org/network/members/profile?UserKey=3de25367-d207-4ee3-aca4-8c40e2804259
    https://connect.informs.org/network/members/profile?UserKey=f36b5ccd-a420-40a6-9085-960288b61668
    https://connect.informs.org/network/members/profile?UserKey=ac090966-69fe-4cc3-bf7d-731ca1d13d81
    https://connect.informs.org/network/members/profile?UserKey=f2d11bb6-119c-4e22-9d47-a1abc945cd81
    https://connect.informs.org/network/members/profile?UserKey=be02a71f-bf90-4c1c-a5be-bef2dfba4473

Comments are closed.